Jump to content

Cancer Diagnosis Program: Difference between revisions

no edit summary
No edit summary
No edit summary
 
Line 3: Line 3:
|ProgramType=Program
|ProgramType=Program
|OrgSponsor=National Cancer Institute
|OrgSponsor=National Cancer Institute
|TopOrganization=National Institutes of Health
|CreationLegislation=National Cancer Act of 1971
|CreationLegislation=National Cancer Act of 1971
|Purpose=To advance the science of cancer diagnosis by supporting research in diagnostic technologies, biomarkers, and pathology. The program aims to enhance early detection, improve diagnostic accuracy, and facilitate personalized treatment strategies.
|Purpose=To advance the science of cancer diagnosis by supporting research in diagnostic technologies, biomarkers, and pathology. The program aims to enhance early detection, improve diagnostic accuracy, and facilitate personalized treatment strategies.
Line 9: Line 10:
|InitialFunding=Part of the National Cancer Institute's budget
|InitialFunding=Part of the National Cancer Institute's budget
|Duration=Ongoing
|Duration=Ongoing
|Historic=false
|Historic=No
}}
}}
'''Cancer Diagnosis Program''' (CDP) is part of the [[National Cancer Institute]] (NCI) focusing on the development and improvement of diagnostic tools and strategies for cancer. The program supports research into new diagnostic methods, including molecular diagnostics, imaging, and pathology, to enable earlier detection and more precise cancer diagnosis, thus improving patient outcomes.
'''Cancer Diagnosis Program''' (CDP) is part of the [[National Cancer Institute]] (NCI) focusing on the development and improvement of diagnostic tools and strategies for cancer. The program supports research into new diagnostic methods, including molecular diagnostics, imaging, and pathology, to enable earlier detection and more precise cancer diagnosis, thus improving patient outcomes.